Results 131 to 140 of about 11,802 (200)

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Risk factors associated with carbapenem-resistant Enterobacterales infections in hospitalized patients: A case-control study. [PDF]

Infez Med
Zambrano-Calderero V, Vera-Álava F, Borges M.   +2 more
europepmc   +1 more source

Prevalence, trend and resistance patterns of carbapenem-resistant Enterobacterales in Bangladesh: a nationwide laboratory-based study. [PDF]

BMC Infect Dis
Rahman A, Sujan MJ, Rizvi SMS, Habib ZH, Hasnat A, Barua HT, Shaw A, MacWright W, Aboushady AT, Stelling J, Holm M, Marks F, Poudyal N.   +12 more
europepmc   +1 more source

Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan. [PDF]

Microbiol Spectr
Ohyama K, Uemura K, Matsumura Y, Hase R, Kato H, Matono T, Itoh N, Hashimoto T, Yamamoto G, Mawatari M, Tsutsumi T, Suzuki T, Suzuki M, Hosoda T, Sakurai A, Asai Y, Tsuzuki S, Hayakawa K, van Duin D, Ohmagari N, Doi Y, Saito S.   +21 more
europepmc   +1 more source

Cluster-Randomized Controlled Trial of Enhanced Carbapenem-Resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital. [PDF]

Clin Infect Dis
Taweesuk A, Rattanaumpawan P, Rachakhom S, Wangchinda W, Assanasen S, Thamlikitkul V.   +5 more
europepmc   +1 more source

Prevalence and risk factors for carbapenem-resistant Enterobacterales colonization in hospitalized children in a provincial hospital in Vietnam. [PDF]

Front Cell Infect Microbiol
Dinh VAT, Trang NNT, Vo ND, Bich NHT, Tran DM, Phuc PD, Duc SL, Dung DM, Goutard F, Velavan TP, Nurjadi D, Hounmanou YMG, Jörgensen B, Song LH, My TN, Loire E, Östholm Å, Nilsson LE, Phan PH, Dalsgaard A, Larsson M, I-CRECT Consortium , Olson L, Hanberger H.   +23 more
europepmc   +1 more source

Microbiological characterization and clinical outcomes of carbapenem-resistant enterobacterales infections in a paediatric hospital in Mexico. [PDF]

BMC Infect Dis
Merida-Vieyra J, Aquino-Andrade A, Tapia-Reyes A, Pérez-González ÓA, A Méndez HE, Bautista-Hernandez R, De Colsa-Ranero A, Aparicio-Ozores G, Belmont-Monroy L.   +8 more
europepmc   +1 more source

Progression from Carbapenem-Resistant Enterobacterales Colonization to Bacteremia in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Cohort Study. [PDF]

Mediterr J Hematol Infect Dis
Rodríguez-Feria D, Díaz-Brochero C, Garzón J, Muñoz Ó.   +3 more
europepmc   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study

Chen-Huan Yu,1 Mao-Song Tsai,2 Chun-Hsing Liao,2 Chia-Jui Yang2 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Infectious Disease, Department of Internal Medicine, Far Eastern Memorial Hospital, New
Tsai MS, Yu CH, Yang CJ, Liao CH
core  

Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025. [PDF]

Front Cell Infect Microbiol
Cao S, Wang P, Liu Y, Qi L, Wang X, Li L, Zhang Z.   +6 more
europepmc   +1 more source